NATIONAL ASSOCIATION FOR PROTON THERAPY HONORS JAY LOEFFLER, MD AS THE 2022 LIFETIME ACHIEVEMENT AWARD RECIPIENT
Contact: JJ Vitale, NAPT Director of Communication ● firstname.lastname@example.org ● 202.919.4536
March 7, 2022 – In recognition of his pioneering work in the field of proton therapy, Dr. Jay Loeffler, physician, and clinical researcher, has been awarded the National Association for Proton Therapy’s 2022 Lifetime Achievement Award. Dr. Loeffler is a world leader with unparalleled experience in the treatment of brain and central nervous system (CNS) tumors and the use of stereotactic radiotherapy. His research, treatment methods and expertise have significantly contributed to the field of proton therapy.
Dr. Loeffler completed his Residency Program in Radiation Oncology at Harvard Medical School in Boston, Massachusetts. He joined the faculty of Joint Center for Radiation Therapy, Department of Radiation Therapy, Harvard Medical School as an instructor and progressed in the academic ranks to be promoted as the Andres Soriano Professor of Radiation Oncology, Harvard Medical School in 2000. He is devoted to educating and mentoring the next generation of Radiation Oncologists.
In addition to his commitment to education, he is dedicated to clinical research to advance the role of proton therapy in the management of patients with cancer. He became the Director of the Francis Burr Proton Therapy Center at Massachusetts General Hospital in 1996. During his tenure as the proton center director and then department chair of MGH, he has overseen the treatment of more than 10,000 children and adults with cancer. In his commitment to clinical research supporting the use of proton therapy, he has served as the principal investigator for NCI funded grant projects and has authored over 400 works on CNS radiotherapy and the importance of proton therapy.
Dr. Dennis Shrieve of University of Utah at Huntsman Cancer Institute states, “Dr. Jay Loeffler has devoted his professional life to the advancement of radiotherapy with the dual role of improving tumor control and limiting normal tissue toxicity. Under his leadership, proton therapy has become available to ever more patients worldwide. He is a passionate advocate for radiotherapy in general and proton therapy in particular”
The National Association for Proton Therapy will present the 2022 Lifetime Achievement Award to Dr. Loeffler during a special program on April 5, 2022, in St. Pete, Florida at the 10th Annual National Proton Conference.
Learn more at www.nationalprotonconference.com
The National Association for Proton Therapy (NAPT) is an independent nonprofit organization founded in 1990 to educate and increase awareness about the clinical benefits of proton therapy. Its members include 40 of the nation’s leading cancer centers many of whom are NCI-designated comprehensive cancer centers and NCCN members. The mission of NAPT is to work collaboratively to raise public awareness of the clinical benefits of proton therapy, ensure patients’ choice and access to affordable proton therapy, and encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy.